Arterial Microcirculation, Macrocirculation and Thrombophilias (NCT01160159) | Clinical Trial Compass
TerminatedNot Applicable
Arterial Microcirculation, Macrocirculation and Thrombophilias
Stopped: COORDINATING INVESTIGATOR'S DECISION
France6 participantsStarted 2010-03-16
Plain-language summary
Rationale: To analyse the arterial state of women with thrombophilia by techniques studying micro and arterial macrocirculation because of a reported and still discussed increase risk in cardio-vascular events in these women.
Primary objective: To measure endothelium dependent vasodilatation (VDE) in controls and in women with thrombophilia.
Who can participate
Age range18 Years – 45 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* healthy volunteers
* 18-45 years old women of child bearing age
* Without any hormonal contraception nor any hormone treatment since at least 3 months
* Without any arterial risk factors (HTA, diabetes, dyslipemia, obesity, including smoking\> 5 cigaret )
* Patient who have signed an inform consent
* With no thrombophilia : normal sample for factor V and II mutations
* Willing to participate to the study
* Adherent to health insurance
* Previous Clinical examination
* women with thrombophilia
* 18-45 years old women of child bearing age
* Without any hormonal contraception nor any hormone treatment since at least 3 months
* Without any arterial risk factors (HTA, diabetes, dyslipemia, obesity, including smoking\> 5 cigaret )
* Patient who have signed an inform consent
* With thrombophilia : normal sample for factor V and II mutations
* Willing to participate to the study
* Adherent to health insurance
* Previous Clinical examination
Exclusion Criteria:
* Women under hormonal contraception or who have stopped it less than 3 months ago
* Women under anticoagulant
* Arterial risk factor : HTA, diabetes, dyslipemia, obesity(BMI\>30), including smoking\> 5 cigarets ), metabolic syndrome, antiphospholipids/anticoagulant antibody, SLE
* History of coronaropathy or of stroke
* Pregnant women or willing to conceive
* Severe liver disease
* Women of less than 18y or older than 45y
* Severe liver diseases
* Patient not willing t…